Therapeutic Targeting of the Proinflammatory IL-6-JAK/STAT Signalling Pathways Responsible for Vascular Restenosis in Type 2 Diabetes Mellitus
Cardiology Research and Practice - United States
doi 10.1155/2019/9846312
Full Text
Open PDFAbstract
Available in full text
Date
January 2, 2019
Authors
Publisher
Hindawi Limited